Search Results

-specific HRQoL issues relevant to a broad spectrum of patients with cancer. 30 The QLQ-C30 included a global health and QoL domain, 5 functional domains (physical, role, emotional, cognitive, and social), 3 symptom domains (fatigue, nausea and vomiting, and pain

. For clinical diagnosis, these difficulties are typically associated with daytime impairment, such as fatigue or excessive sleepiness at least 3 times a week for 30 minutes or more for at least 1 month. Nearly 80% of women undergoing chemotherapy for

-controlled trial . J Clin Oncol 2001 ; 19 : 2865 - 2874 . 2 Berndt E Kallich J McDermott A . Reductions in anaemia and fatigue are associated with improvements in productivity in cancer patients receiving chemotherapy . Pharmacoeconomics 2005 ; 23

reported significant improvement in nutrition and ambulation. Due to new bony metastases, nivolumab and ipilimumab were added in January 2020 while maintaining encorafenib and binimetinib. While on this regimen for 4 months, with fatigue as the only AE

, in combination with ostalgia, fatigue, and asthenia, can create balance, gait, and gross and fine motor coordination difficulties. 22 Deficits can range from mild issues resulting in subtle changes that can be readily addressed with occupational

past medical history presented with right upper quadrant abdominal pain, fatigue, poor appetite, and an approximately 20-lb weight loss over 2 to 3 months. She denied alcohol or illicit drug use. She had smoked half a pack of cigarettes per day for many

A review of randomized controlled trials by a panel of clinical and research experts confirmed that during and after cancer treatment, exercise is safe and beneficial for reducing many common sequelae of cancer treatment, such as fatigue

, HCL is characterized by symptoms of fatigue and weakness, and most patients will present with splenomegaly (symptomatic or asymptomatic) and/or hepatomegaly, pancytopenia, and uncommonly peripheral lymphadenopathy. 2 Additionally, patients may also

study of JBR.10 participants, global QOL declined in both the observation and chemotherapy arms, with both groups experiencing high symptom burden related to fatigue and postsurgical pain. A higher proportion of patients in the observation arm reported

physical symptom burden that has been shown to adversely affect their quality of life and psychological outcomes. 2 , 3 Although it is known that patients with MPNs report frequent fatigue, early satiety, or pruritus depending on their MPN type and